Behçet disease in the developing world

International Ophthalmology Clinics

Volumn 50, Issue 2, 2010, Pages 87-98

  Tugal Tutkun, Ilknur ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEHCET DISEASE; CLINICAL FEATURE; DEMOGRAPHY; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DISEASE COURSE; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW;

BEHCET SYNDROME; DEVELOPING COUNTRIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE;

EID: 77951055280     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181d2e030     Document Type: Review

References (74)

1. Behçet H. Ü ber rezidivierende aphthöse durch ein Virus verursachte GeschwÜre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152-1157.
2. Dilsen N. History and development of Behçet's disease. Rev Rheum Engl Ed. 1996;63:512-519.
3. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50:297-350.
4. GÜl A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy. 2005;4:81-83.
5. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLAB51. Ann Rheum Dis. 2001;60:996-1002.
6. Direskeneli H. Autoimmunity versus autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology. 2006;45:1461-1465.
7. Yavuz S, Elbir Y, Tulunay A, et al. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet's disease etiopathogenesis. Rheumatol Int. 2008;28:401-406.
8. Verity DH, Marr JE, Ohno S, et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54:213-220.
9. Keino H, Okada AA. Behçet's disease: global epidemiology of an old Silk Road disease. Br J Ophthalmol. 2007;91:1573-1574.
10. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982;100:1455-1458.
11. Azizlerli G, Köse AA, Sarica R, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803-806.
12. Yurdakul S, GÜnaydin I, TÜzÜn Y, et al. The prevalence of Behçet's syndrome in a rural area in Northern Turkey. J Rheumatol. 1988;15:820-822.
13. Idil A, Gurler A, Boyvat A, et al. The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol. 2002;9:325-331.
14. TÜzÜn Y, Yurdakul S, Mat MC, et al. Epidemiology of Behçet's syndrome in Turkey. Int J Dermatol. 1996;35:618-620.
15. Cakir N, Dervis E, Benian O, et al. Prevalence of Behçet's disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol. 2004;22(suppl 34):S53-S55.
16. Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behçet's disease in the north of Israel. Clin Rheumatol. 2007;26:555-560.
17. Jaber L, Milo G, Halpern GJ, et al. Prevalence of Behçet's disease in an Arab community in Israel. Ann Rheum Dis. 2002;61:365-366.
18. Davatchi F, Jamshidi AR, Banihashemi AT, et al. Prevalence of Behcet's disease in Iran: a WHO-ILAR COPCORD stage I study. APLAR J Rheumatol. 2007;10: 239-243.
19. Nakae K, Masaki F, Hashimoto T, et al. Recent epidemiological features of Behçet's disease in Japan. In: Wechsler B, Godeau P, eds. Behçet's Disease. International Congress Series. Amsterdam: Excerpta Medica; 1993:145-151.
20. Kaneko F, Nakamura K, Sato M, et al. Epidemiology of Behçet's disease in Asian countries and Japan. In: Zouboulis CC, ed. Adamantiades- Behcet's Disease. New York: Kluwer/Plenum; 2003:25-29.
21. Al-Dalaan A, Al Ballaa S, Al Sukait M, et al. The prevalence of Behçet's disease in Al Qassim region of Saudi Arabia. In: Hamza M, ed. Behçet's Disease. Tunisia: Publications Adhoua; 1997:170-172.
22. Al-Rawi ZS, Neda AH. Prevalence of Behçet's disease among Iraqis. In: Zouboulis CC, ed. Adamantiades-Behcet's Disease. New York: Kluwer/Plenum; 2003:37-41.
23. Zhang Z, Peng J, Hou X, et al. Clinical manifestations of Behcet's disease in Chinese patients. APLAR J Rheumatol. 2006;9:244-247.
24. Mok CC, Cheung TC, Ho CTK, et al. Behçet's disease in southern Chinese patients. J Rheumatol. 2002;29:1689-1693.
25. Assaad-Khalil SH, Kamel FA, Ismail EA. Starting regional registry for patients with Behçet's disease in North-West Nile Delta region in Egypt. In: Hamza M, ed. Behçet's Disease. Tunisia: Publications Adhoua; 1997:173-176.
26. Sanchez Burson J, Grandal Y, Mendoza M, et al. Clinical characteristics, HLA antigen and mortality in Behçet's syndrome in Spain. In: Bang D, Lee E, Lee S, eds. Behçet's Disease. Seoul: Design Mecca Publishing; 2000:604.
27. Salvarani C, Pipitone N, Catanoso MG, et al. Epidemiology and clinical course of Behçet's disease in the Reggio Emilio area of northern Italy: a seventeen-year population-based study. Arthritis Rheum. 2007;57:171-178.
28. Lannuzel A, Lamaury I, Charpentier D, et al. Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings. J Neurol. 2002; 249:410-418.
29. Mousa AR, Marafie AA, Rifai KM, et al. Behçet's disease in Kuwait, Arabia. A report of 29 cases and a review. Scand J Rheumatol. 1986;15:310-320.
30. Crespo J, Ribeiro J, Jesus E, et al. Behçet's disease-particular features at the central zone of Portugal. In: Wechsler B, Godeau P, eds. Behçet's Disease. International Congress Series. Amsterdam: Excerpta Medica; 1993:207-210.
31. Zouboulis CC, Kötter I, Djawari D, et al. Current epidemiological data from the German registry of Adamantiades-Behçet's disease. In: Zouboulis CC, ed. Adamantiades- Behcet's Disease. New York: Kluwer/Plenum; 2003:43-48.
32. Kötter I, GÜnaydin I, StÜbiger N, et al. Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens. 2001;58:166-170.
33. Zouboulis CC. Epidemiology of Adamantiades-Behçet's disease. In: Zierhut M, Ohno S, eds. Immunology of Behçet's Disease. Lisse: Swets & Zeitlinger Publ; 2003:1-16.
34. Ek L, Hedfors E. Behçet's disease: a review and report of 12 cases from Sweden. Acta Dermatol Venereol (Stockh). 1993;73:251-254.
35. Chamberlain MA. Epidemiological features of Behçet's syndrome. In: Lehner T, Barnes CG, eds. Behçet's Syndrome. Clinical and Immunological Features. London: Academic Press; 1979:213-222.
36. Chamberlain MA. Behçet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977;36:491-499.
37. Mishima S, Masuda K, Izawa Y, et al. The eighth Frederick H Verhoeff lecture. Behcet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979; 77:225-279.
38. Poon W, Verity DH, Larkin GL, et al. Behçet's disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol. 2003;87:876-878.
39. Wakefield D, McClusky P. Behçet's syndrome: ocular features in an Australian population. Aust N Z J Ophthalmol. 1990;18:129-135. (Pubitemid 20253192)
40. Barra C, Belfort R Jr, Abreu MT, et al. Behçet's disease in Brazil-a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol. 1991;35:339-346.
41. Yoshida A, Kawashima H, Motoyama Y, et al. Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology. 2004;111:810-815.
42. Akiyama K, Numaga J, Yoshida A, et al. Statistical analysis of endogenous uveitis at Tokyo University Hospital. Jpn J Ophthalmol. 2006;50:69-71.
43. Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277-286.
44. Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2008 [Epub ahead of print].
45. Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1997;235:5-9.
46. Ando K, Fujino Y, Hijikata K, et al. Epidemiological features and visual prognosis of Behçet's disease. Jpn J Ophthalmol. 1999;43:312-317.
47. Shahram F, Davatchi F, Nadji AN, et al. Recent epidemiological data on Behçet's disease in Iran. The 2001 Survey. In: Zouboulis CC, ed. Adamantiades-Behcet's Disease. New York: Kluwer/Plenum; 2003:31-36.
48. Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285-293.
49. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicenter study. Br J Dermatol. 2007;157:901-906.
50. Kitaichi N, Ohno S. Behçet disease in children. Int Ophthalmol Clin. 2008;48:87-91.
51. Saricaoglu H, Karadogan SK, Bayazit N, et al. Clinical features of late-onset Behçet's disease: report of nine cases. Int J Dermatol. 2006;45:1284-1287.
52. Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behçet disease: a descriptive study of 36 cases. Am J Ophthalmol. 2003;136:1114-1119.
53. Kone-Paut I, Gorchakoff-Molinas A, Weschler B, et al. Paediatric Behçet's disease in France. Ann Rheum Dis. 2002;61:655-656.
54. Cheng YK, Thong BY, Chng HH. Behcet's disease: experience in a tertiary rheumatology centre in Singapore and a review of the literature. Ann Acad Med Singapore. 2004;33:510-514.
55. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol. 2003;42:346-351.
56. Yang P, Fang W, Meng Q, et al. Clinical features of Chinese patients with Behçet's disease. Ophthalmology. 2008;115:312-318.
57. Sachdev N, Kapali N, Singh R, et al. Spectrum of Behçet's disease in the Indian population. Int Ophthalmol. 2008 [Epub ahead of print].
58. Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3:148-155.
59. Kitaichi N, Miyazaki A, Iwata D, et al. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol. 2007;91:1578-1582.
60. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078-1080.
61. The International Study Group for Behçet's Disease. Evaluation of diagnostic ("classification") criteria in Behçet's disease-towards internationally agreed criteria. Br J Rheumatol. 1992;31:299-308.
62. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82:60-76.
63. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373-380.
64. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Neovascularization of the optic disc in Behçet's disease. Jpn J Ophthalmol. 2006;50:256-265.
65. Atmaca LS. Fundus changes associated with Behçet's disease. Graefes Arch Clin Exp Ophthalmol. 1989;227:340-344.
66. Tugal-Tutkun I, CingÜ K, Kir N, et al. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet Uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246:1169-1177.
67. Kaçmaz RO, Kempen JH, Newcomb C, et al. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146:828-836.
68. Khairallah M, Attia S, Yahia SB, et al. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa. Int Ophthalmol. 2008 [Epub ahead of print]
69. GÜl A. Standard and novel therapeutic approaches to Behçet's disease. Drugs. 2007;67:2013-2022.
70. Kötter I, Zierhut M, Eckstein AK, et al. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol. 2003;87:423-431.
71. Tugal-Tutkun I, GÜney-Tefekli E, Urgancioglu M. Results of interferon-alfa therapy in patients with Behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2006;244:1692-1695.
72. Tugal-Tutkun I, Mudun A, Urgancioglu M, et al. Efficacy of infliximab in the treatment of uveitis resistant to the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease. An open-label trial. Arthritis Rheum. 2005;52:2478-2484.
73. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656-1662.
74. Sut N, Seyahi E, Yurdakul S, et al. A cost analysis of Behçet's syndrome in Turkey. Rheumatology. 2007;46:678-682.